Updated:
Cardinal Partners
O VALOR DO SEU INVESTIMENTO | A Cardinal Partners é uma gestora de investimentos que investe em empresas listadas no mercado acionário brasileiro.
Cardinal Partners
O VALOR DO SEU INVESTIMENTO | A Cardinal Partners é uma gestora de investimentos que investe em empresas listadas no mercado acionário brasileiro. Investimos em empresas nas quais identificamos vantagens competitivas sólidas, retorno do negócio atrativo, e que tenham um valor de mercado substancialmente abaixo do seu valor justo. Nosso horizonte de investimento é de longo prazo.
General information
Firm type
Private Equity
Year founded
1996
Location
Region
North America
Country
United States
City
Chapel Hill
Corporate office
Princeton, NJ, United States
Additional offices
San Francisco, CA, United States
Principals
John A. Hurley
Managing Partner
Robert C. Minicucci
Managing Partner
David L. Berman
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Cardinal Partners?
The firm's website lists John Clarke and John Park as principals, and they appear to be the central decision-makers. A wider group of venture partners contributes domain and operating expertise, but the partnership structure suggests Clarke and Park control investment committee decisions.
How does Cardinal Partners source proprietary deal flow?
Cardinal builds deal flow through longstanding relationships with academic medical centers, hospital systems, and biotechnology researchers, and by selectively co-founding companies at inception. The firm often acts as the first institutional investor, which creates an origination channel that competes on company formation rather than auction processes.
Does Cardinal Partners participate in fund commitments or only direct deals?
Cardinal invests directly in early and growth-stage healthcare companies and does not publicly describe a fund-of-funds or LP commitment program. Its model is based on taking board seats and supplying strategic and regulatory guidance to operating companies.
What investment stages does Cardinal Partners typically target?
The firm targets seed, start-up, and growth stages. Its historical positioning as a first institutional check means it frequently leads or co-leads Series A rounds, with selective participation in later-stage recapitalizations when existing portfolio companies require follow-on capital.
Which sectors does Cardinal Partners explicitly avoid?
Cardinal has not published a formal exclusion list, but its 25-year track record shows no activity in consumer internet, enterprise SaaS, or hard tech outside of healthcare. The firm's portfolio is exclusively concentrated in biotechnology platforms, diagnostics, healthcare IT, and tech-enabled care-delivery models.
What is Cardinal Partners' known posture on co-investments alongside external GPs?
Cardinal has co-invested alongside firms such as Polaris, Atlas Venture, MVM Life Science Partners, and Mithra in syndicated biotech rounds. The firm appears open to syndicating with other healthcare-specialist and generalist venture firms, particularly in capital-intensive drug-development deals.
Does Cardinal Partners maintain philanthropic structures, and how are they separated?
No philanthropic foundation or donor-advised structure is publicly linked to Cardinal Partners. The firm operates as a for-profit venture partnership and has not disclosed a separate philanthropic vehicle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: